• KOL
    • Fdg Pet
    • Kimiteru Ito
    • Kimiteru Ito: Influence Statistics

      Kimiteru Ito

      Kimiteru Ito

      Show email address

      Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan | Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. | ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Kimiteru Ito:Expert Impact

      Concepts for whichKimiteru Itohas direct influence:Fdg pet,Fdg uptake,Kaposi sarcoma,Computed tomography,Emission tomography,Fluorodeoxyglucose f18,Positron emission,Bone marrow.

      Kimiteru Ito:KOL impact

      Concepts related to the work of other authors for whichfor which Kimiteru Ito has influence:Fdg pet,Emission tomography,Cardiac sarcoidosis,Bone marrow,Unknown origin,Rheumatoid arthritis,Molecular imaging.

      KOL Resume for Kimiteru Ito

      Year
      2022

      Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

      2021

      Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan

      2020

      Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, 104-0045, Chuo-ku, Tokyo, Japan

      2019

      Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

      2018

      Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10065, New York, NY, USA

      Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

      2017

      Department of Radiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan

      2016

      Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY

      Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

      2015

      Department of Radiology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-Cho, Itabashi-ku, Tokyo, 173-0015, Japan

      2014

      From the *Department of Radiology, National Center of Neurology and Psychiatry; and †Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan.

      Department of Diagnostic Radiology, Tokyo Metropolitan Medical Center of Gerontology, Tokyo, Japan

      2013

      Department of Rehabilitation, National Hospital Organization Tokyo National Hospital, and, Department of Radiology, National Center of Neurology and Psychiatry, Tokyo, Japan

      2012

      From the *Department of Radiology, National Center of Neurology and Psychiatry, Tokyo, Japan; and †Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan.

      Department of Radiology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551 Japan

      2011

      Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan

      Department of Radiology, National Center of Neurology and Psychiatry

      2010

      Department of Nuclear Medicine, Saitama Medical University International Medical Center, 1397-3 Yamane, Hidaka, Saitama, Japan

      2009

      From the *Department of Nuclear Medicine, Saitama Medical University International Medical Center; Departments of †Neurology, and ‡Radiology, International Medical Center of Japan, Tokyo, Japan.

      Department of Nuclear Medicine, Saitama Medical University, International Medical Center, Saitama, Japan

      2008

      1Division of Nuclear Medicine, International Medical Center of Japan, Tokyo, Japan; 2Department of Radiology, International Medical Center of Japan, Tokyo, Japan; and 3Department of Urology, International Medical Center of Japan, Tokyo, Japan

      2007

      Department of Nuclear Medicine, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan

      2006

      Division of Nuclear Medicine, International Medical Center of Japan, Tokyo, 162-8655 Japan

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Kimiteru Ito is among the top experts in the world.
      Concept World rank
      fdg uptake patterns #1
      volume msa #1
      fdg methionine #1
      findings 18f #1
      lesions 11c #1
      recurrences nonsquamous #2
      mtx therapy management #2
      emission tomography eortc #2
      harmonized suvmax #2
      criteria harmonized #2
      fdg pet mtxrml #2
      harmonized response #2
      patients prognosis prediction #2
      harmonized fdg #2
      harmonization types #2
      misdiagnoses addition #2
      harmonized percist #2
      detecting recurrences #2
      18ffdg 11ccholine pet #2
      rheumatoid arthritis mtxrml #2
      radiotherapy iacr #2
      icis 18f #2
      fuo clinical impact #2
      pet methotrexate #2
      uh grade #2
      nh large #2
      mtx fdg #2
      harmonized impercist #2
      mtxrml #2
      suv bone marrow #2
      imaging spectrum pitfalls #2
      hnscc iacr #2
      impercist 00001 #2
      positron f18 fdg #2
      interpretation hnscc #2
      harmonized eortc #2
      uptake foci article #2
      recurrences chemotherapy #2
      migrated seeds #2
      “ravat #2
      Sign-in to see all concepts, it's free!

      Prominent publications by Kimiteru Ito

      KOL-Index: 14920

      ObjectiveFluorodeoxyglucose (FDG) uptake in joint lesions in patients with rheumatoid arthritis (RA) reportedly represents the degree of synovial inflammation. Most previous studies have focused on small joints, and the application of whole-body positron emission tomography (PET) combined with computed tomography (CT) (PET/CT) for the evaluation of inflammatory activity in large joints has not been well studied.MethodsEighteen patients with RA underwent FDG-PET/CT. FDG uptake in the ...

      Known for Large Joints | Rheumatoid Arthritis | Fdg Uptake | Computed Tomography | Synovial Inflammation
      KOL-Index: 13665

      ObjectiveTo evaluate the clinical value of 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for the diagnosis of fever of unknown origin (FUO), we performed a Japanese multi-center retrospective survey.MethodsA total of 81 consecutive patients with FUO who underwent FDG-PET at 6 institutions between July 2006 and December 2007 were retrospectively evaluated. FDG uptake was visually evaluated using a 4-grade scale. The efficacy of FDG-PET for the evaluation of FUO, ...

      Known for Unknown Origin | Diagnosis Fuo | Fdg Pet | Fluorodeoxyglucose F18 | Infectious Diseases
      KOL-Index: 13178

      PurposeThe purpose of this prospective study was to evaluate the usefulness of 18F-fluorodeoxyglucose (FDG) and 11C-choline positron emission tomography (PET)/computed tomography (CT) for detecting recurrences of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy. Additionally, we surveyed the time period during which an effective negative predictive value could be maintained after the first follow-up PET/CT examination and estimated the optimal ...

      Known for Advanced Head | Choline Pet | Neck Cancer | Combined Intra | Arterial Chemotherapy
      KOL-Index: 13007

      In FDG-PET for abdominal malignancy, the liver may be assumed as an internal standard for grading abnormal FDG uptake both in early images and in delayed images. However, physiological variables of FDG uptake by the liver, especially the effects of blood glucose level, have not yet been elucidated.

      METHODS: FDG-PET studies of 70 patients examined at 50 to 70 min after injection (60 ± 10 min: early images) and of 68 patients examined at 80 to 100 min after injection (90 ± 10 min: delayed ...

      Known for Blood Glucose Level | Fdg Uptake | Delayed Images | Liver Suv | Pet Studies
      KOL-Index: 12220

      The aim of this study was to investigate the correlations between (18)F-FDG uptake by bone marrow and various hematological parameters. Forty-eight patients who underwent FDG-PET/CT studies and also received hematological examinations within 5 days before or after the PET study were included in this study. All patients had not received chemotherapy. FDG uptake by bone marrow was measured as a standardized uptake value (SUV) on three-dimensional PET/CT fusion images, and the uptake ratio ...

      Known for Bone Marrow | Fdg Uptake | Hematological Parameters | Blood Cell | Neutrophil Count
      KOL-Index: 11454

      A new tracer, 4'-[methyl-(11)C]-thiothymidine ((11)C-4DST), has been developed as an in vivo cell proliferation marker based on the DNA incorporation method. This study evaluated the potential of (11)C-4DST PET/CT for imaging proliferation in non-small cell lung cancer (NSCLC), compared with (18)F-FDG PET/CT.

      METHODS: Eighteen patients with lung lesions were examined by PET/CT using (11)C-4DST and (18)F-FDG. We constructed decay-corrected time-activity curves of 9 major regions as the ...

      Known for Cell Lung | Proliferation Imaging | 11c4dst Pet | 18f Fdg | Correlation Coefficient
      KOL-Index: 10962

      Immune checkpoint inhibitors (ICIs) are now commonly used to treat patients with metastatic malignant melanoma. Although concerns have been raised that the inflammatory response induced by ICIs may limit the ability of 18F-FDG PET/CT to assess tumor response, systematic analyses on the use of 18F-FDG PET/CT in this setting are mostly lacking. Thus, we set out to evaluate the association between tumor response on 18F-FDG PET/CT and prognosis in patients with metastatic malignant melanoma ...

      Known for Metastatic Melanoma | Fdg Pet | Tumor Response | Patients Pmd | New Lesions
      KOL-Index: 10694

      AIMS: The purpose of this study was to evaluate the clinical impact of addition of [(11)C]Pittsburgh compound-B positron emission tomography ((11)C-PiB PET) on routine clinical diagnosis of Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI), and to assess diagnostic agreement between clinical criteria and research criteria of the National Institute on Aging-Alzheimer's Association.

      METHODS: The diagnosis in 85 patients was made according to clinical criteria. Imaging ...

      Known for Clinical Impact | Emission Tomography | Mild Cognitive Impairment | Magnetic Resonance Imaging | Diagnosis Dementia
      KOL-Index: 10565

      ObjectiveThe purpose of this study was to evaluate the usefulness of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiating pulmonary artery sarcoma from pulmonary embolism.Materials and methodsWe evaluated three patients with pulmonary artery sarcoma and 10 patients with proximal pulmonary embolism (6 men and 7 women, ranging in age from 35 to 94 years). All the patients had evidence of perfusion defects in their proximal pulmonary arteries on ...

      Known for Pulmonary Embolism | Fdg Pet | Artery Sarcoma | Fluorodeoxyglucose F18 | Computed Tomography
      KOL-Index: 10481

      In multiple system atrophy with predominant parkinsonism (MSA-P), several voxel-based morphometry (VBM) studies have revealed gray matter loss; however, the white matter volume changes have been rarely reported. We investigated the volume changes of white matter as well as gray matter by VBM. A retrospective MRI study was performed in 20 patients with MSA-P and 30 age-matched healthy controls. We applied VBM with statistical parametric mapping (SPM8) plus diffeomorphic anatomical ...

      Known for White Matter | Spm8 Dartel | Multiple Atrophy | Volume Loss | Msa Patients
      KOL-Index: 10456

      PurposeIpilimumab induces durable remission in about 15–20% of patients with metastatic melanoma. However, reliable predictors of response to ipilimumab are currently lacking. Whole-body metabolic tumor volume (wMTV) has been shown to be a strong prognostic factor in a variety of malignancies treated with chemotherapy, but few results have been reported for patients treated with immunotherapy. The purpose of this study was to investigate the prognostic value of wMTV and other metabolic ...

      Known for Melanoma Patients | Computed Tomography | Metabolic Tumor | Positron Emission | Multivariate Analyses
      KOL-Index: 10040

      Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA) is a recently established disorder that is a subtype of neurodegeneration with brain iron accumulation (NBIA). We presented the first case report of SENDA of a 39-year-old female. She had psychomotor retardation from childhood and remained static for two decades. Then, at the age of 30, she developed severe dystonia and parkinsonism. Brain MRI revealed T2-weighted hypointensity signal in the globus pallidus ...

      Known for Static Encephalopathy | Tensor Imaging | Childhood Neurodegeneration | Adulthood Senda | Substantia Nigra
      KOL-Index: 9880

      N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-(11)C-methoxy-N-methylbenzamide ((11)C-ITMM) is a potential radioligand for mapping metabotropic glutamate receptor type 1 (mGluR1) in the brain by PET. The present study was performed to determine the safety, distribution, radiation dosimetry, and initial brain imaging of (11)C-ITMM in healthy human subjects.

      METHODS: The multiorgan biodistribution and radiation dosimetry of (11)C-ITMM were assessed in 3 healthy human subjects, ...

      Known for Metabotropic Glutamate | Radiation Dosimetry | 11c Itmm | Radioactivity Plasma | Type 1
      KOL-Index: 9051

      PURPOSE: The aims of this study were to evaluate the possibility of using (11)C-methionine ((11)C-MET) and (11)C-4'-thiothymidine ((11)C-4DST) whole-body PET/CT for the imaging of amino acid metabolism and DNA synthesis, respectively, when searching for bone marrow involvement in patients with multiple myeloma (MM) and to compare these findings with those for (18)F-FDG PET/CT and aspiration cytology.

      METHODS: A total of 64 patients with MM, solitary plasmacytoma, monoclonal gammopathy of ...

      Known for Multiple Myeloma | Fdg Pet | Bone Marrow | Fluorodeoxyglucose F18 | Solitary Plasmacytoma
      KOL-Index: 9046

      ObjectivesTo investigate fluorodeoxyglucose (FDG) accumulation in large joints, bursas, and large vessels in patients with polymyalgia rheumatica (PMR) using 18-FDG positron emission tomography/computed tomography (PET/CT) and to differentiate PMR from similar diseases.MethodsFourteen untreated patients with active PMR and 17 control patients with rheumatoid arthritis (n = 11) or other active rheumatic diseases (n = 6) underwent 18-FDG PET/CT. FDG uptake in large joints, bursas and ...

      Known for Polymyalgia Rheumatica | Computed Tomography | Positron Emission | Fluorodeoxyglucose F18 | Pmr Patients

      Key People For Fdg Pet

      Top KOLs in the world
      #1
      Abass A Alavi
      fdg pet emission tomography fluorodeoxyglucose f18
      #2
      Richard L Richard
      fdg pet positron emission tomography breast cancer
      #3
      Otto S H Hoekstra
      distant metastases fdg pet emission tomography
      #4
      Wolfgang Andreas Weber
      fdg pet prostate cancer positron emission tomography
      #5
      Schwaiger Schwaiger
      positron emission tomography prostate cancer pet imaging
      #6
      Steven Mark Larson
      prostate cancer positron emission tomography monoclonal antibody
      Select a search phrase   fdg pet , fdg pet pet , fdg pet imaging , fdg pet patients , fdg petct

      Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan | Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. | Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukij

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.